Blackrock Health Sciences Trust (BME) Getting Very Positive Media Coverage, Report Shows

Media stories about Blackrock Health Sciences Trust (NYSE:BME) have trended very positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Blackrock Health Sciences Trust earned a media sentiment score of 0.50 on Accern’s scale. Accern also gave news articles about the company an impact score of 44.6857955772959 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Shares of Blackrock Health Sciences Trust (NYSE:BME) traded up $0.44 during mid-day trading on Wednesday, reaching $33.85. The company’s stock had a trading volume of 50,387 shares, compared to its average volume of 49,842. Blackrock Health Sciences Trust has a 52-week low of $32.81 and a 52-week high of $38.00.

The business also recently announced a monthly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be paid a $0.20 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 7.09%. The ex-dividend date is Wednesday, February 14th.

COPYRIGHT VIOLATION WARNING: “Blackrock Health Sciences Trust (BME) Getting Very Positive Media Coverage, Report Shows” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at

Blackrock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a non-diversified, closed-end management investment company (the Trust). The Trust’s investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.

Insider Buying and Selling by Quarter for Blackrock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with's FREE daily email newsletter.

Leave a Reply